News
Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...
23hon MSN
Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced ...
Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how would we even know?
Gene-editing companies hold potential to treat and cure diseases caused by genetic variants. ... Ayvakit (avapritinib), an inhibitor of KIT and PDGFRA proteins, ...
A St. Louis startup is pioneering a new approach to gene editing in crops, and the National Science Foundation just gave it a ...
The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...
Gene editing helped a desperately ill baby thrive. Scientists say it could someday treat millions. Story by LAURA UNGAR • 2w. A baby born with a rare and dangerous genetic disease is growing and ...
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, with a personalized CRISPR gene-editing therapy.The treatment corrects ...
A baby born with a rare and dangerous genetic disease is thriving after getting an experimental gene editing treatment made just for him. Gene editing helped a desperately ill baby thrive.
Baby saved by gene-editing therapy 'graduates' from hospital, goes home. KJ Muldoon was diagnosed with a rare, deadly genetic disease after he was born. By Sony Salzman. June 4, 2025, 11:09 AM.
Gene therapies can be extremely expensive to develop. The baby, KJ Muldoon of Clifton Heights, Pennsylvania, is one of 350 million people worldwide with rare diseases, most of which are genetic.
A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results